title: A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.
authors: Department of Dermatology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan Department of Hematology and Oncology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
authors: Masahiro
authors: M
authors: Kamata
authors: Makoto
authors: M
authors: Sugaya
authors: Tomomitsu
authors: T
authors: Miyagaki
authors: Koya
authors: K
authors: Sonoda
authors: Yohei
authors: Y
authors: Ichimura
authors: Hiroshi
authors: H
authors: Mitsui
authors: Shinichi
authors: S
authors: Sato
authors: Yasuhiko
authors: Y
authors: Kamikubo
authors: Mineo
authors: M
authors: Kurokawa
mesh_terms: D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D018951:Antigens, CD20 / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000188:drug therapy* / Q000378:metabolism; D008775:Methylprednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D013601:T-Lymphocytes / Q000378:metabolism*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; C571759:R-CHOP protocol; D003561:Cytarabine; D000069283:Rituximab; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D011241:Prednisone; D008775:Methylprednisolone